Language
Search
News
- Bruker Introduces SampleXpress™, a New and Easy-to-Use Autosampler that Delivers Increased...
- Bruker Announces Order by Kennedy Krieger Institute for Ultra-High Field 11.7 Tesla Pre-Clinical...
- Bruker Announces Major Multi-Systems NMR Order from Vanderbilt University
- MRI Newsletter 05/2010
- Bruker Introduces New Ascend™ High Performance High-Field NMR Magnet Series
Upcoming EPR Events
Bruker BioSpin’s EPR/ESR product lines
From Bench-Top to the most flexible EPR Research Platform
Bruker BioSpin offers three product lines to match the demands of every EPR spectroscopist and researcher to supply the best-possible solution for the task at hand.
The ELEXSYS-II, the next step in instrument evolution, provides the research platform on which all modern EPR techniques are built. The system supports multi-frequency EPR from 1 to 263 GHz in CW and FT modes as well as EPR imaging for animal research or material science. The world record sensitivity in CW-EPR at X-band demonstrates the outstanding performance of this instrument class. Multi-resonance is the domain of the recently introduced DICE-II unit, a powerful add-on for Electron-Nuclear Double and Triple Resoance (ENDOR). The E 580-400 unit for Electron-Electron Double Resonance (ELDOR) is the popular accessory for distance measurements.
The EMXplus and the EMXmicro are the two successors of the well-known EMX series. Both spectrometers further widen and enhance CW-EPR performance on an affordable yet professional basis. For the first time in this spectrometer class, the EMXplus features CW-ENDOR, a technique to disentangle and simplify complex EPR spectra.EMX
The e-scan product line is the result of Bruker BioSpin’s dedication to industrial applications of EPR/ESR. Bruker BioSpin’s EPR application group is assisting and involved in bringing today’s fundamental research applications into industry and quality control (QC). The e-scan bench-top product line is comprised of EPR readers for turn-key QC-applications and EPR spectrometers for medical and pharmaceutical research on free radicals (ROS/RNS).